GB201410695D0 - Uses of oligouronates in cancer treatment - Google Patents
Uses of oligouronates in cancer treatmentInfo
- Publication number
- GB201410695D0 GB201410695D0 GB201410695A GB201410695A GB201410695D0 GB 201410695 D0 GB201410695 D0 GB 201410695D0 GB 201410695 A GB201410695 A GB 201410695A GB 201410695 A GB201410695 A GB 201410695A GB 201410695 D0 GB201410695 D0 GB 201410695D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- oligouronates
- cancer treatment
- cancer
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB201410695A GB201410695D0 (en) | 2014-06-16 | 2014-06-16 | Uses of oligouronates in cancer treatment |
EP14820882.0A EP3086847A1 (en) | 2013-12-23 | 2014-12-23 | Uses of oligouronates in cancer treatment |
AU2014372566A AU2014372566B2 (en) | 2013-12-23 | 2014-12-23 | Uses of oligouronates in cancer treatment |
JP2016560044A JP2017501221A (en) | 2013-12-23 | 2014-12-23 | Use of oligouronates in cancer treatment |
PCT/EP2014/079178 WO2015097224A1 (en) | 2013-12-23 | 2014-12-23 | Uses of oligouronates in cancer treatment |
MX2016008304A MX2016008304A (en) | 2013-12-23 | 2014-12-23 | Uses of oligouronates in cancer treatment. |
CA2934950A CA2934950A1 (en) | 2013-12-23 | 2014-12-23 | Uses of oligouronates in cancer treatment |
US15/107,424 US20160346313A1 (en) | 2013-12-23 | 2014-12-23 | Uses of oligouronates in cancer treatment |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB201410695A GB201410695D0 (en) | 2014-06-16 | 2014-06-16 | Uses of oligouronates in cancer treatment |
Publications (1)
Publication Number | Publication Date |
---|---|
GB201410695D0 true GB201410695D0 (en) | 2014-07-30 |
Family
ID=51266661
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB201410695A Ceased GB201410695D0 (en) | 2013-12-23 | 2014-06-16 | Uses of oligouronates in cancer treatment |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB201410695D0 (en) |
-
2014
- 2014-06-16 GB GB201410695A patent/GB201410695D0/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA201607415B (en) | Antibody-drug-conjugate and its use for the treatment of cancer | |
IL250677B (en) | Treatment of cancers using anti-nkg2a agents | |
HUE053654T2 (en) | Combinations of fgfr- and cmet-inhibitors for the treatment of cancer | |
IL276733A (en) | Use of eribulin in the treatment of cancer | |
HRP20190888T8 (en) | Igf-1r antibody-drug-conjugate and its use for the treatment of cancer | |
IL248767B (en) | Trimethoxyphenyl-benzimidazole compound for use in the treatment of cancer | |
HK1231561A1 (en) | Cancer treatment | |
IL251903B (en) | Apilimod for use in the treatment of colorectal cancer | |
GB201420533D0 (en) | Use of Nanomaterials in treating cancer | |
GB201409363D0 (en) | Skin cancer treatment | |
SG10202001388YA (en) | Use of ureidomustine (bo-1055) in cancer treatment | |
GB201408297D0 (en) | Treatment of cancer | |
GB201417456D0 (en) | Treatment of cancer | |
GB201410695D0 (en) | Uses of oligouronates in cancer treatment | |
GB201409362D0 (en) | Treatment of cancer | |
GB201405449D0 (en) | Treatment of cancer | |
GB201405075D0 (en) | Treatment of cancer | |
ZA201403006B (en) | Composition for use in treatment of cancer | |
GB201512723D0 (en) | Treatment of cancer | |
GB201507928D0 (en) | Treatment of cancer | |
GB201417465D0 (en) | Treatment of cancers | |
GB201504617D0 (en) | Treatment of cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |